Skip to main content

Find Clinical Trials

Home
Conditions
Cutaneous Adverse Drug Reactions (CADR)

Clinical trial condition

Cutaneous Adverse Drug Reactions (CADR)

Explore clinical trials studying Cutaneous Adverse Drug Reactions (CADR). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Cutaneous Adverse Drug Reactions (CADR) trial results

Not Yet Recruiting

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

NCT07110662

Conditions: Chemically-Induced Disorders, Cutaneous Adverse Drug Reactions (CADR), Dermatitis, +17 more
Locations: Reference Center for Toxic, Toxin and Toxidermal Bullous Dermatoses - E. Herriot Hospital Lyon, France

View Trial Details